Note 3 - Selected Balance Sheet Data - Changes in Carrying Amount of Goodwill (Details) $ in Thousands |
3 Months Ended |
|---|---|
|
Dec. 31, 2021
USD ($)
| |
| Beginning balance | $ 843,067 |
| Acquisitions | 0 |
| Eminence impairment | (8,275) |
| Currency translation | (2,736) |
| Ending balance | 832,056 |
| Protein Sciences [Member] | |
| Beginning balance | 392,717 |
| Acquisitions | 0 |
| Eminence impairment | (8,275) |
| Currency translation | (2,610) |
| Ending balance | 381,832 |
| Diagnostics and Genomics [Member] | |
| Beginning balance | 450,350 |
| Acquisitions | 0 |
| Eminence impairment | 0 |
| Currency translation | (126) |
| Ending balance | $ 450,224 |
| X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of loss recognized that results from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|